Mobi-C Cervical Disc Prosthesis for use at One Level
Highridge Medical, LLC · Decision date Sep 16, 2026
What did the FDA decide?
The FDA entry P110002/S040 records a 30-day notice for Highridge Medical, LLC covering the Mobi-C cervical disc prosthesis used at one level. Per the source statement, the notice covers adding CAM Bioceramics as a raw material supplier of hydroxyapatite powder used in the coating of Mobi-C inferior and superior endplates, and qualifying CeraTek sealing equipment for the final packaging pouch, both at the same Viant facility. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier.
The identifier links this notice to the premarket approval P110002, but the entry describes specific supplier and equipment changes rather than an approval of the whole device system. The statement gives its own purpose; it is not independent evidence of safety or clinical effectiveness, and the supplied fields do not state coating performance, seal validation results, or any clinical outcome.
FDA approval order statement
addition of a new raw material supplier (CAM Bioceramics) for hydroxyapatite powder used in the coating of Mobi-C inferior and superior endplates, and qualification of a new sealing equipment (CeraTek) for sealing of the final packaging pouch of Mobi-C devices at the same Viant facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P110002/S040
- Regulatory pathway
- PMA supplement
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- Decision code
- OK30
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, intervertebral disc.
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P110002. Subsequent supplements may change the device or its indications.
FDA decision timeline
P110002 · Original PMA
MOBI-C CERVICAL DISC PROSTHESIS (ONE-LEVEL INDICATION)
P110002/S040 received
Application receipt date recorded by FDA.
P110002/S040 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P110002. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110002
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Highridge Medical, LLC | PMA approval | Aug 7, 2013 | FDA |
Explore the linked device profile
Other records with product code MJO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BAGUERAC Cervical Disc ProsthesisP250042/S002 | Spineart USA, Inc. | PMA supplement | Sep 22, 2026 | FDA |
Synergy DiscP250028/S003 | Synergy Spine Solutions, Inc. | PMA supplement | Sep 17, 2026 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
prodisc C NovaP070001/S031 | Centinel Spine, LLC | PMA supplement | Sep 9, 2026 | FDA |
| Spineart USA, Inc. | PMA approval | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Highridge Medical, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 10225 Westmoor Dr., Westminister, CO, 80021
Sources and methodology
- Original FDA record: P110002/S040
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



